P-148Nimotuzumab bi-weekly/low dose combined to chemotherapy in advanced pancreatic cancer: A clinical study. (20th June 2018) - Lima, M; Jennifer, V; Dominguez, C; Robin, G; Dunia, M; Alexander, O; Giselle, G; Amparo, M; Ivan, R; Noyde, B; Soriano, J